Effects of aerobic exercise on asthma quality of life : a pilot study by Wright, Alicia







Presented in Partial Fulfillment of the Requirements for the Degree of Master of




© Alicia Wright, 2009













Your file Votre référence
ISBN: 978-0-494-67215-0
Our file Notre référence
ISBN: 978-0-494-67215-0
NOTICE:
The author has granted a non-
exclusive license allowing Library and
Archives Canada to reproduce,
publish, archive, preserve, conserve,
communicate to the public by
telecommunication or on the Internet,
loan, distribute and sell theses
worldwide, for commercial or non-
commercial purposes, in microform,
paper, electronic and/or any other
formats.
The author retains copyright
ownership and moral rights in this
thesis. Neither the thesis nor
substantial extracts from it may be
printed or otherwise reproduced
without the author's permission.
AVIS:
L'auteur a accordé une licence non exclusive
permettant à la Bibliothèque et Archives
Canada de reproduire, publier, archiver,
sauvegarder, conserver, transmettre au public
par télécommunication ou par l'Internet, prêter,
distribuer et vendre des thèses partout dans le
monde, à des fins commerciales ou autres, sur
support microforme, papier, électronique et/ou
autres formats.
L'auteur conserve la propriété du droit d'auteur
et des droits moraux qui protège cette thèse. Ni
la thèse ni des extraits substantiels de celle-ci
ne doivent être imprimés ou autrement
reproduits sans son autorisation.
In compliance with the Canadian
Privacy Act some supporting forms
may have been removed from this
thesis.
While these forms may be included
in the document page count, their
removal does not represent any loss
of content from the thesis.
Conformément à la loi canadienne sur la
protection de la vie privée, quelques
formulaires secondaires ont été enlevés de
cette thèse.
Bien que ces formulaires aient inclus dans





Exercise and Asthma Quality of Life
Alicia Wright
Quality of life (QOL) in chronic disease populations is becoming increasingly important.
Exercise is beneficial in many chronic disease populations and improves QOL. A paucity
of studies has evaluated the impact of aerobic exercise in adults with asthma. This pilot
study examined the efficacy of a 12-week aerobic exercise intervention on quality of life
in sedentary adults with asthma. Four adults with asthma were recruited into this pilot
study and completed the Asthma Quality of Life Questionnaire (AQLQ) prior to and after
completing the exercise intervention. Repeated measure analyses of variance (ANOVA)-
type models using general linear models were conducted using SAS. Following the
exercise intervention, participants demonstrated clinically significant improvements in
total AQLQ (4.27 ± 0.72 to 5.49 ± 0.96), but these changes were not statistically
significant (F=4.63, p=.120). However, participants did demonstrate statistically
significant improvements in the symptom domain of the AQLQ (3.75 ± 0.59 to 5.31 ±
1 .09; F=10.96, p=.045), as well as in levels of asthma control as assessed by the
Asthma Control Questionnaire (2.54 ± 0.74 to 0.82 ± 0.52; F=36.03, p=.009) and the
Asthma Control Test (1 3.25 ± 3.30 to 21 + 1 .83; F=23.44, p=.01 7). Results suggest that
exercise may play an important role in asthma care and should be considered in addition
to traditional asthma treatment due to the impact it has on asthma control and asthma
quality of life. Further larger efficacy studies are needed, and potential mechanisms of
this relationship should be explored.
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Chapter 1: Introduction
Quality of life (QOL) is an increasingly important outcome in clinical populations. QOL is
a term that is broadly used and has not been clearly defined, though it is generally
referred to as one's level of satisfaction with one's life and the ability to enjoy life (1-3).
Asthma is a chronic respiratory condition, which is characterized by chronic
inflammation, with symptoms such persistent cough and shortness of breath (4). Asthma
prevalence is on the rise in Canada, such that 2.3 million people reported physician-
diagnosed asthma in 2008 (up from 2.2 million in 2007) (5, 6). Unfortunately, people with
asthma have been shown to have worse QOL than people without asthma (7).
Exercise is beneficial to general health status as well as to a diversity of clinical
populations. It improves cardiorespiratory and cardiovascular health, and general well-
being (8). Exercise can also decreases morbidity of numerous conditions such as
obesity, type Il diabetes, and hypertension (9). Exercise has been used as an adjunct
treatment in cardiac, cancer, and chronic obstructive pulmonary disease (COPD)
populations with much improvement in clinical status (10, 11).
Exercise in respiratory disease populations such as COPD has proven to be important to
increase physical function and QOL. However little is known about how exercise impacts
asthma QOL in adults with asthma. Studies examining the impact of exercise
interventions in children with asthma have shown that not only are these interventions
safe, but they have several positive outcomes including significant improvements in
asthma QOL (12, 13). Unfortunately, most exercise intervention studies among adults
included QOL measures that were not specific to asthma thus not allowing us to capture
aspects of QOL that are specific to asthma. Moreover, in the literature, overall levels
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asthma symptom control and short-acting bronchodilator (rescue medication) use in
particular have been suggested as potential mechanisms underlying changes in asthma
QOL (14, 15). However, to our knowledge, no study has evaluated asthma control in
adults following an exercise intervention. Finally, intervention studies that evaluated
medication use did not specify medication type (i.e., did not differentiate between
bronchodilators, which are short-acting rescue medications that are taken to treat acute
attacks, and inhaled corticosteroids, which are controller medications that are taken daily
to prevent asthma attacks and treat inflammation), thus providing no information on how
exercise can impact bronchodilator use, which is an important measure of asthma
control. Overall, the paucity of studies on the impact of exercise interventions on QOL in
adults with asthma has been confirmed in a recent systematic review of physical activity
and asthma (16).
The objective of this pilot study was to determine whether a 12-week aerobic exercise
intervention in adults with asthma could improve asthma QOL, asthma control and
bronchodilator use. In addition we evaluated if changes in asthma QOL were correlated
with changes in asthma control and bronchodilator use. We hypothesized that a 12-
week aerobic exercise intervention would significantly improve asthma QOL, and that
these improvements would be correlated with improvements in asthma control and
bronchodilator use.
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Chapter 2: Review of Literature
2a. Asthma in Canada
Asthma is a chronic respiratory condition of the lungs characterized by reversible airway
obstruction, airway hyperresponsiveness, and chronic airway inflammation in response
to stimuli such as dust, pollen, cigarette smoke and exercise. Symptoms of asthma
include: shortness of breath, wheezing, and persistent cough (4). According to the World
Health Organization, (WHO; (17)) approximately 300 million people have asthma and
255,000 mortalities were caused by asthma in 2005. According to Statistics Canada, 8%
of the population over the age of 12 (over 2.2 million people) were diagnosed with
asthma in 2005 (6). Symptoms and attacks can become so severe that many individuals
with asthma require hospitalization. Approximately 80,000 Canadians were hospitalized
for asthma in the short three-year span between April 1998 and March 2001 (18). Figure
1 represents the hospitalization rate in Canada between 2004 and 2005(19).





























Source: Centre for Chronic Disease Prevention and Control, Public Health Agency of Canada, using
data from Hospital Morbidity File (acute and chronic), Canadian Institute for Health Information.
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In general, asthma is directly related to increased work and school absences, an inability
to perform household chores, a restriction of social activities (20) and a general
decrease in QOL (21-23). In terms of health services, data from the National Population
Health Survey (NPHS) (24) (a Canadian survey that looked at general health in 1996),
revealed that 60% of people with asthma visited a physician, with 1 7% visiting a
physician four or more times. In addition, 18% of Canadians visited an emergency
department, and over 5% required hospitalization. The NPHS also found that 56% of all
patients with asthma had an attack which corroborates the results of a separate survey
of asthmatics in which more than 50% of adults said they had uncontrolled asthma (25);
thus depicting the poor level of asthma control in Canada. The health burden caused by
poor asthma control comes with high costs. Based on resource utilization, including
emergency department visits in 2000-2001, the total cost of uncontrolled asthma in
Canada in 2004 was estimated to be approximately $162 million (26).
2b. Pathophysiology
As previously mentioned, asthma is a complex disease and is characterized by airway
obstruction (usually partially or completely reversible), airway hyperresponsiveness in
response to stimuli, and chronic inflammation (27, 28). These characteristics are used to
diagnose and differentiate asthma from other respiratory diseases such as COPD.
2b.1 Airway obstruction
To diagnose asthma, it is necessary to have an objective measure of airway obstruction
(28) in addition to a complete patient history and symptom report. Forced expiratory
volume in one second (FEV1) (28), forced vital capacity (FVC), and peak expiratory flow
(PEF) are the most commonly used spirometrie tests to obtain measures of airway
obstruction (29). FEV1 is the volume of air expired during the first second of a forced
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expiratory manoeuvre (30). FVC ¡s the maximal volume of air that can be forcefully
expired. The FEVi and FVC manoeuvres are done following a maximal inhalation. The
normal values of these measures are predicted from the age, sex, height and weight
based on various population studies. FEV1 can be represented as an absolute value or
as the FEV10Zo of the predicted value for a person's age, sex, height and weight. The
degree of obstruction is classified as: mild >80%, moderate 60-80%, severe <60% of
predicted FEV1 (31). Airway obstruction reversibility, generally defined as a rapid change
in FEV1, is determined if FEV^ncreases by >12% and 200ml compared to baseline FEV1
after the administration of a short-acting bronchodilator (28, 29, 32). Due to the fact that
a number of other respiratory conditions may impact FEV1 (e.g. COPD), and that a
person with asthma may have a normal FEV1 when they are not having an exacerbation
(30), the ratio of FEV1 to FVC becomes useful in properly assessing the degree of airway
obstruction. An asymptomatic individual with asthma may have an abnormal FEV1ZFVC
with normal ratio ranges being from 0.75-0.90 (29). A ratio of 0.75 means that 75% of
the total expired air is expired in the first second. PEF, which is the maximum rate of
expiration, is highest when there is minimal obstruction, and lowest during an
exacerbation. Although PEF meters are relatively inexpensive and portable, because
they may underestimate airway obstruction, they should not be used over spirometrie
measures of FEV1 to assess airway obstruction, but rather used as a means of tracking
patient progress over time (29).
2b.2 Airway Hyperresponsiveness
In individuals with asthma symptoms and borderline lung function, defined by normal
FEV1 FEV1ZFVC, further testing is often necessary to confirm or exclude asthma (33).
The next step would be to test for airway hyperresponsiveness (AHR) which is
characterized as maximal airway narrowing in response to a stimulus (34).
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Bronchoprovocation tests use provocative agents such as metacholine, histamine,
mannitol, or exercise challenge (28, 33) to assess AHR. Most frequently, metacholine
challenges are employed, requiring patients to inhale increasing concentrations of
metacholine until there is a 20% decrease in FEV1. The test is considered negative for
AHR if FEV1 does not drop by 20% following the administration of 8mg/ml of metacholine
(30). After coming into contact with a trigger in an environmental setting, AHR is
responsible for the onset of symptoms as well as the variation in airway obstruction (29).
The initial AHR response is due to bronchoconstriction, which is the contraction of the
smooth muscle surrounding the bronchi causing airway narrowing (35) (Figure 2 (36)).
However, there is also a latent long-term response which is driven by inflammation.
Figure 2 Pre-/Post-bronchoconstriction
I
Axial chest hyperpolarized helium magnetic resonance scan of a patient with mild asthma
before (A) and after (B), demonstrating acute bronchoconstriction and ventilation defects. (36)
2b.3 Inflammation
The main component of asthma is inflammation (which occurs about 3 hours after
contact (37)), provoked by a trigger, and any diagnosis of asthma should be confirmed
by evidence of inflammation (29). The chronic inflammatory nature of asthma remains
poorly understood, however, it is believed that the predominant expression of T-2 helper
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over the T- 1 helper cytokines may predict the durability of the chronicity and the severity
of asthma (38). Mast cells, eosinophils, T lymphocytes, dendritic cells, macrophages,
and neutrophils are inflammatory cells found in the airways of individuals with asthma
and key mediators of asthma include cytokines, histamine, chemokines, nitric oxide
(NO), and prostaglandin D2 (29, 39).
Although the involvement of many inflammatory cells makes this process complex, a
simplistic model of asthma would be the following: When an attack is triggered,
bronchoconstriction occurs, coughing and shortness of breath begins, excess mucous is
produced, and the inflammatory process is elicited. The increased mucous production
further narrows the airways, making it much more difficult for air to reach the lungs.
Wheezing may begin as other symptoms such as coughing and shortness of breath
continue to worsen. The repeated trigger exposure results in the recurrence of this
inflammatory cascade in which inflammatory markers (those mentioned above) are
released. While bronchoconstriction is the first immediate response to a trigger, it may
only last minutes in contrast to the inflammatory response, which can last for several
hours or days after initial contact with a trigger (37).
2c. Medication
Asthma medication is used to control the underlying inflammation as well as control
manifestations of the disease. There are two types of medications used for asthma
treatment, reliever and controller medication (40). When asthma symptoms develop, an
individual with asthma would require the use of their reliever medication. The reliever is
an inhaled short-acting bronchodilator that is used to reverse bronchoconstriction and
increase airway diameter (29). Figure 3 (41) depicts the effect of the reliever medication
on the smooth muscle surrounding the airway. This medication is only used during an
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asthma exacerbation and does not treat the underlying inflammation. Although inhaled
short-acting ß2-agonist are commonly prescribed, there exist numerous other relievers
such as short-acting theophylline, inhaled anticholinergics, and short-acting oral ß2-
agonist (29, 42). A sign of asthma control deterioration is when use of the reliever
medication is increased, and at this point, asthma treatment should be reassessed (29).
Common side effects of these medications included restlessness, trembling, and
tachycardia (29).





Top left is during airway constriction and bottom right is after reliever medication is taken, airway diameter is
increased.
Controller medication is taken every day and is used to treat the underlying
inflammation, whether asthma symptoms are present or not. Inhaled corticosteroids
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eliever
(ICS) are very effective in asthma control maintenance and are used as standard
treatment for asthma (43). ICS have been demonstrated to not only be effective for the
treatment of inflammation, but also for overall symptom and AHR reduction, as well as
improved lung function and QOL (44). Side effects of long-term high ICS doses include
oropharyngeal disorders (45), decreased bone mineral density, and skin bruising (46).
As valuable as they are as anti-inflammatories, there exists a variety of other controller
medications on the market including oral glucocorticosteroids, leukotrienes, and long-
acting inhaled ß2-agonist (40). However, none of these medications cure asthma, and if
they are discontinued asthma control deteriorates within weeks to months (47, 48).
2d. Asthma Control and Severity
Asthma control and asthma severity are often confused; however these two phenomena
are different. Asthma control refers to the extent to which the manifestations and
symptoms of the disease are present or absent (49). These manifestations include day
and nocturnal symptoms, activity limitations, use of short-acting bronchodilators, and
lung function (29). In contrast, asthma severity defines the severity of the underlying
disease, characterized by the level of inflammation, as well as its responsiveness to
treatment (29, 33). Asthma severity can be classified into four categories; mild
intermittent, mild persistent, moderate persistent, and severe persistent. These four
categories are based on the frequency of certain symptoms, the degree of airway
obstruction and variability, and the dose of controller medication prescribed (50).
Overlapping classification features for both control and severity include: daily and
nocturnal symptoms, and lung function (29). Despite this overlap, previous research has
shown that these two phenomena assess different processes in patients with asthma
(51). In addition, it must be understood that a person can have severe asthma and good
control, while another person can have mild asthma but very poor control.
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Taking into account the number of hospitalizations, emergency room visits, and asthma
exacerbations experienced by individuals with asthma, it is apparent that asthma
remains shockingly poorly controlled in Canada. With more than 50% of Canadians
having a deplorable level of asthma control (25), there results a negative cycle of
increased number of hospital visits, medication use, and symptoms severity, with
simultaneous decreases in QOL.
2e. Quality of Life
QOL is a broad term that has not been limited to one distinctive definition (1, 3) and has
been evaluated in numerous studies without being defined (2). In addition, some
authors have used the terms QOL and health status interchangeably, however, it has
been shown that these are two different constructs (52). Gill et al. (2) defined QOL as "a
reflection of the way that patients perceive and react to their health status and to other
non-medical aspects of their lives". QOL can be divided into: general QOL, health
related QOL, and disease-specific QOL. The Center for Disease Control in the USA
defines general QOL as: "overall sense of well-being with a strong relation to a person's
health perception and ability to function (53)." General QOL is a multidimensional
construct that can be subdivided into various domains which influence one's perception
of their general QOL such as: financial status, occupational environments, relationships,
and health (54). Health-related QOL is predominantly influenced by a person's health
status and clinical treatment and is a subset of one's general QOL (54). The most
influential domains of health-related QOL appear to be: physical functioning, social
functioning, and mental status (52). Different diseases and their treatment interventions
(i.e. cancer versus asthma), affect a person's perception of their QOL in a variety of
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ways, thus leading to the term disease-specific QOL, which assess the QOL of specific
clinical populations.
It is important to recognize that a variety of questionnaires have been created to
evaluate general QOL, health-related QOL, and disease-specific QOL. General QOL
encompasses various domains; therefore measures evaluating general QOL are not
heavily dependent on health status but will look at the many factors that influence QOL.
In contrast, disease-specific QOL questionnaires focus on aspects of QOL that are
affected by the specific disease of interest (i.e. asthma). Characteristics specific to
asthma such as night awakening and weekly symptoms have a negative impact on
mental health which is a subset of QOL (7), thus contributing to the fact that individuals
with asthma have decreased QOL compared to their non-asthma peers (7).
2g. Aerobic Exercise and Asthma
Exercise is defined as activities that are planned and structured, and done to improve or
maintain components of physical fitness and health (55, 56). Aerobic exercises are
activities that require the use of oxygen in the energy producing system, such as playing
a soccer game, in contrast to anaerobic exercise, like weight lifting, that require the use
of an energy producing system that is not heavily reliant on oxygen. Aerobic exercise
has numerous benefits in healthy populations, such as, improved cardiovascular and
cardiorespiratory capacity, as well as improved QOL (8). Similarly, aerobic exercise
programmes are favourable for populations with various health conditions, such as
coronary artery disease (10), other cardiovascular diseases (57), and COPD (11).
Collectively, the evidence suggests that aerobic exercise may also have a positive
impact on asthma morbidity such as medication use, and QOL in patients with asthma.
However, the majority of the studies were conducted in children or used QOL
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questionnaires that were non-specific to asthma, thus resulting in a lack of knowledge
about the positive effects of aerobic exercise on asthma QOL in adults.
2h. Impact of Exercise on Quality of Life
Studies conducted in other clinical populations found improvements in QOL after
exercise training programmes. For example, a meta-analysis of the effects of exercise
on QOL in women with or who survived breast cancer revealed that 3 of the 14 studies
that provided adequate data of QOL found a significant in improvement in two QOL
questionnaires following an exercise programme (58). The two QOL measures were
Functional Assessment of Cancer Therapy-General (4.58, 95%CI 0.35 to 8.8) and the
Functional Assessment of Cancer Therapy-Breast (6.62, 95% Cl 1.21 to 12.03) (58).
Two of these interventions were comprised of only aerobic exercise, with the other
combining both aerobic and resistance training. Exercise interventions were a minimum
of 6 weeks long, 2-5x/week (the duration of the sessions were not mentioned). Similar
studies have been done using aerobic training and/or resistance training in populations
such as coronary artery disease, with similar improvements in QOL (57, 59-61).
Although there are a limited number of studies done looking primarily at the effects of
aerobic exercise on asthma QOL in adults (see Table 1.), in general, it appears that
individuals with asthma and other respiratory diseases have an improved QOL following
participation in an exercise intervention. For example, in a study done by Basaran et al.
(13) children with mild-moderate asthma were randomized to an exercise intervention or
a control group. All sessions included a 15-minute warm-up and callisthenics, 30-35
minutes of submaximal basketball training, and a 10-minute cool-down, which included
flexibility exercise. When comparing pre- and post- exercise training, the exercisers
scores' on the Paediatric Asthma Quality of Life Questionnaire (PAQLQ) increased from
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5.03 ±0.7 to 6.23 ±0.4 (p<.001) (13). Exercisers also had significant improvements on
each subscale of the PAQLQ (activity p<.001, symptoms p<.001 , emotions p<.001). A
significant difference in QOL scores was also noted when comparing the exercise group
to the control group post-training, with the exercisers scoring 1 .09 times higher than the
controls (p=.01) (13). However, as depicted by pre- and post-intervention measures in
Figure 4 (13), both exercise and control groups had improvements in QOL. The strength
of this study is that they found an improvement in QOL, as measured by an asthma-
specific questionnaire. However, this study was done in children, so although there was
an improvement in QOL, we do not know how these results may translate to adults with
asthma. In addition, information regarding participants' previous levels of physical
activity was not measured or reported. This prevents us from determining the magnitude
of change due to physical activity. There was also no mention of exercise intensity level,
thus we do not know if children training at higher intensities improved more than those
who trained at lower intensities, which could affect the mean overall change in QOL.




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Weisgerber et al. (62) evaluated the effects of two intensities exercise on QOL in
children with asthma. Children between the ages of 7-14 were randomized to either
swimming or golf exercise intervention, both lasting 9-weeks. For both programmes,
there were 27 sessions, each lasting 1 hour. The swimming intervention was chosen as
the high intensity exercise and the golf intervention was chosen as the moderate
intensity intervention. The swimming intervention contained two components, each
lasting 30 minutes. The first component was swimming lessons that were done at
participants' swimming levels. The second component (Swim Team) was comprised of
four phases: interval training, endurance training, relay races and water games. The golf
intervention included three components: teaching and review, time to practice skills, and
group games taking 10, 30 and 20 minutes respectively. Authors evaluated QOL before
and after the interventions using Juniper's PAQLQ. Analysis of the swimmers and
golfers revealed a statistically significant improvement in PAQLQ score (p=0.02),
however this improvement of 0.4 was not clinically significant. These results are the
combined results of both groups due to the fact that they did not recruit the minimum
number of participants to make group comparisons (62). A drawback of this study it that
the authors did not provide any information on the participants' prior physical activity
level, which may be one reason why we did not observe any clinical significant changes
in PAQLQ (66). Also, participants in both groups attended less than 75% of the
sessions, with some attending as low as 10% of the sessions which could have also
affected the results (62). Although they used an asthma-specific QOL measurement tool
due to the fact that this was done in children we have no notion of how these results
apply to adults with asthma.
The study done by Fanelli et al. (12) is also among the limited number of studies
conducted looking at the effects of exercise training on QOL in children with asthma.
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This study evaluated children, aged 7-15, with asthma. Prior to group randomization
(exercise or control), there was a two-week run-in period for the purpose of confirming
disease stability. During this time, all the children received two, weekly educational
classes lasting 2 hours each (12). The core of the classes were based on a videotape of
the asthma 'ABCs' (which are informational tapes about asthma), and also included
lessons on asthma pathophysiology and medication use. Moreover, classes discussed
how to use a written action plan, which is a guide written by the patient's physician
describing how to monitor symptoms and adjust medication if asthma control worsens
(67). Exercise sessions consisted of a 1 5-minute warm-up including stretching, 30-
minutes of aerobic training (treadmill and/or cycle), 30 minutes of upper-body, lower-
body and abdominal endurance exercises, and a 15 minute cool-down, stretching and
relaxation period all under supervision. At the end of the study, children in the training
group had a significant improvement in QOL measured by the PAQLQ compared to the
controls. Improvements were seen in the total score (p<0.04) as well as all subscales
(activity p<0.04, symptom p<0.02, emotional function p<0.03). Although children had not
been participating in any regular exercise programme at the time of study entry, we do
not know to what extent children were physically active, nor was physical activity
defined. Again, level of physical activity prior to study entry could have impacted
outcome measures (66). The strength of this study, like the Basaran et al, is the use of
an asthma-specific questionnaire to assess QOL changes in both groups and provides
evidence that exercise can positively impact QOL in children with asthma; however this
may not translate directly to an adult population.
In one of the few adult studies in this area, Cambach et al. (63) assessed QOL changes
in response to an exercise programme. This study was composed of asthma and COPD
patients. Participants were randomized to either rehabilitation (exercise plus drug
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treatment) or a control condition (drug treatment only), for a duration of three months,
and then switched conditions (crossed-over) for the remaining three months. Exercise
training consisted of 2, 90-minute sessions per week of aerobic exercise (cycle
ergometer, rowing, and stair walking), and 1, 45-minute session per week of recreational
activities (e.g. hockey, etc.). There was a significant improvement in QOL in all
participants when the rehabilitation period was compared to the control period (63).
Asthma participants who completed the exercise intervention first still showed an
improved QOL (compared to at baseline) after three months of exercise cessation. This
suggests that there is a residual effect of exercise on QOL even three months after
exercise cessation, which could provide evidence of long-term effects of aerobic
exercise on asthma. Nonetheless, there was a decline in QOL 3 months post-
intervention. Although this study used a respiratory questionnaire to assess QOL, it was
not asthma-specific, so it may not capture certain aspects of QOL that are unique to
asthma. In addition, the use of recreational activities, which may have been more
ecologically valid, indicates that it was impossible to verify if the participants were
achieving the desired level of exercise intensity (60% of max heart rate). Nevertheless,
to our knowledge, this is the first study evaluating QOL in adults with asthma after
completing only an exercise intervention. So although this study used a non-specific
measurement tool, it captured the fact that there is a potential for QOL improvement
following this type of intervention in adults with asthma.
Haave et al. (64) conducted a pulmonary rehabilitation programme (PRP) in a group of
adults with asthma and COPD. The programme included educational lectures, social
sharing with other participants, lifestyle change support and physical exercise. No
specific details of these planned activities were included in the study methods. Sessions
of education or exercise were done 3-4 times per week for 45 minutes. QOL, assessed
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by the Perceived Quality of Life Scale, improved significantly after the PRP, however,
after 6 months, the improvements diminished (64). Although there was an improvement
in QOL, due to the multidimensional nature of the PRP, we do not know how exercise
alone impacted QOL in the patients with asthma. As this study was a mixed (COPD and
asthma) group of adults, it was not possible to use an asthma-specific questionnaire.
This again presents the same problem as with the Cambach et al. study, in that the
specific impact of exercise on asthma QOL cannot be assessed.
Foglio et al. (65) evaluated the effects of a PRP on QOL in adults with asthma and
COPD. The training programme consisted of four components: upper/lower and
abdominal muscle exercises, education sessions for both patients and families,
nutritional programmes and psychosocial counselling, and exercise. The entire
programme lasted for 8-10 weeks, and included 3, 3-hour sessions per week. The
exercise component was supervised, with patients doing increments until they reached
30-mins of cycling continuously at 50-70% of the maximal load. This intensity was
determined from the incremental cycle ergometer test done prior to programme entry.
QOL was evaluated using the St-George's Respiratory Questionnaire (SGRQ). They
found a significant improvement in QOL at the end of the programme as well as 12-
months after finishing the programme. However, it is difficult to assess which component
of the PRP most influenced QOL. On the SGRQ, a change of >4 is clinically significant
and asthma participants went from a total SGRQ of 41 ±15 to 29±16 12-months post-
training (65). The authors also did a follow-up study where all participants were
randomized to either PRP2 or control condition. They found that there was no significant
difference in SGRQ score in either group following PRP2; however both groups had
maintained a better SGRQ score than at baseline. Due to the mixed cohort, they could
not use an asthma-specific measurement of QOL. Also, we are unable to disentangle
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the degree of improvement in QOL due to exercise alone due to the multidisciplinary
nature of the intervention. Although this method of QOL assessment was not specific to
asthma and the intervention included several components, this does highlight that
changes in QOL due to a PRP (including exercise) can have positive long-term residual
effects on QOL.
In a study conducted by Emtner et al. (8) aspects of QOL were measured using a visual
analog scale (VAS). The VAS was created to examine "feelings" related to asthma
symptoms and its impact on the ability to carry out physical and occupational activities.
However, "feelings" were not defined in this study, making this an ambiguous measure.
The programme was a 10-week programme consisting of 2-5 days/week of swimming
interval training at a target heart rate of 80-90% of their maximum predicted heart rate.
Training included a 12-minute warm-up period followed by 5 sets of interval training. The
intervals consisted of large muscle movements, for which 1 set included 2 minutes of
intensive and 1.5 minutes of mild movements. The sessions concluded with a 7-minute
cool-down period and 10 minutes of stretching. The VAS was given before, at 2, 6, and
after the 10-week programme (Figure 5 (8)). At the end of the programme, participants
had an improvement in their feelings in regards to exercise. Although this study had
some strengths, including the fact that it was one of the few looking at exercise training
in adults with asthma and that they demonstrated that asthma does not prevent people
from doing high intensity exercise, it was also limited due to the fact that it did not
directly measure QOL, nor all aspects of QOL that are affected by asthma (e.g.
environment).
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The answers to questions 4 and 5 were not analyzed at 2 weeks. Questions: 1. 1 am able to exercise at
maximal intensity (always-never). 2. I am afraid of experiencing breathlessness when exercising (never-
always). 3. I have asthma symptoms (never-always). 4. 1 can cope with my job/studies (without restrictions-
not at all). 5. 1 am able to leave home for more than 24h (always-never)
Despite these encouraging results, few studies have evaluated the effects of an aerobic
exercise intervention on asthma-specific QOL in adults, (see Table 1) thus (as pointed
out above) not allowing the determination of how results in children may translate to
adults. If, as suggested above, there is a benefit of aerobic exercise on QOL in adults,
this raises the question of what mechanisms might lead to such an improvement. It has
been suggested that changes in asthma control, bronchodilator use are correlated to
QOL thus may play a role in potential improvements in QOL (68, 69).
2i. Asthma Control
As previously mentioned, asthma control is an important aspect of asthma, and is a
separate construct from asthma severity. More than half of Canadians with asthma have
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poor control (24), making the focus of asthma treatment achieving optimal levels of
asthma control. This is extremely important due to the fact that poor asthma control has
a negative impact on individuals with asthma, particularly on asthma QOL, as well as on
the healthcare system and society.
2i.1 Impact of Exercise on Asthma Control
To our knowledge, no studies have examined the impact of an exercise intervention on
asthma control in adults. A study done by Sly et al. (70) evaluated the effects of an
exercise intervention on children with asthma. Twenty-six children, aged 9-13 years old,
were assigned to either general exercise and breathing exercise intervention or the
control condition. Sessions took place 3x /week, 2 hours each, for 13 weeks, and
consisted of a variety of exercises: running, abdominal strengthening, callisthenics, wall
ladder, rope climbing, tumbling and parallel bars, as well as breathing control swimming
and swimming skills. Furthermore, children were given a home exercise programme
which included breathing exercises, trunk strengthening exercises, relaxation and
stretching. Sly et al. (70) assessed number of wheeze days and found a significant
difference between the exercise and control groups such that the exercise group had a
significant decrease in number of wheeze days (mean: 31.3 pre-exercise to 5.7 during
exercise), though there was a significant difference between the groups at baseline (i.e.
exercisers had a higher number of wheeze days than the controls (70)). Although
wheeze was significantly improved in the exercise group, it is not possible to determine
how much of this effect resulted from exercise alone due to the fact the inclusion of
breathing exercises in the intervention.
Huang et al. (71) also assessed number of wheeze days and asthma attacks in children
following an exercise programme. This programme was a community-based, city-wide
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swimming program for children in Baltimore, Maryland. It was designed to take place
twice a year, two months each time. Sessions were done 3x /week, for an hour per
session. The 45 children ranged from 6-12 years old and were compared to a group of
age, sex and asthma severity-matched controls. Data on number of wheeze days and
asthma attacks was collected for a duration of 12-months prior to starting the
programme as well as during 12-months following programme completion. Huang et al.
(71) found that there was a statistically significant decrease in number of wheeze days
per patient (|66%), number of wheeze days per patient per month (J.67%), number of
attacks (J.78%) and number of attacks per patient (J.79%) 12 months after the exercise
programme compared to their baseline data. These results were also statistically
significant when compared to the control group. Although this only partially represents
asthma control, it is an important finding because it demonstrates that there is a residual
effect of exercise on asthma in children.
Szentágothai et al. (72) evaluated the effectiveness of a community-based exercise
programme in children with asthma. The programme consisted of 3 exercise
components: teaching swimming, swim training, and complete exercise programme. The
first was to teach 5-6 year olds how to do the backstroke and sessions took place 5x
/week for 4 weeks, for an hour each session. The second consisted of swim competition
between children (individual or team), ending each session with a ball game. This took
place for one hour, 2x /week. The third was a complete programme that included
swimming, gymnasium exercises, and running exercises. Pool sessions were done 2x /
week for one hour, with one gymnasium exercise (e.g. relay races, etc.) and one running
exercise (gradually increasing the running distance) (72). Children's asthma was
classified based on number of wheeze days: <20 days= mild, 21-60 days=moderate and
>60=severe. At the end of the first year of the programme, 121 children with asthma
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were assessed via questionnaires sent to their parents. The exercise programme
improved asthma classification such that many children changed classification (i.e. from
severe to moderate, etc.) In addition, the number of hospitalizations decreased from 27
to 12 following the first year (72). This demonstrates that exercise in children with
asthma can have a positive impact on symptoms such as wheezing, and suggests that
we may have similar improvements in adults.
The Basaran study (13) also evaluated symptom scores in children 31 children with
asthma after 8-weeks of basketball training (described in section 2h). Symptom scores
were assessed on a 4-point scale, from 0-3; specifically 0=no symptoms and 3= severe
symptoms. Prior to starting the programme, children in the exercise group had a
significantly higher symptom score (Mean ± SD: 0.74±0.5) than those in the control
group (p=0. 02). Following the 8-week programme, the exercisers had a significantly
lower symptom score (Mean ± SD: 0.20 ± 0.8) when compared to baseline (p<0.01).
Although this is only one component of asthma control, it gives an excellent insight of the
impact of an exercise intervention in children with asthma; however we do not know how
these results translate to adults.
Weisgerber et al. evaluated the change in symptoms in 45 children with asthma
(described in section 2h) (62). Symptoms were assessed using the symptom subscale of
the PAQLQ. Parents' assessment of their children's symptoms was evaluated using the
Living with Asthma Questionnaire Index (LWAQ). Following the 9-week intervention
(swimming or golf), children had a clinically and statistically significant decrease in both
asthma symptom measures, (PAQLQ, p=.01; LWAQ, p<.001). In addition, participants,
on average, had fewer emergency consultations to the clinic due to exacerbations during
the intervention when compared to 2-months prior to starting the intervention (62).
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Although symptoms and average number of clinic visits due to exacerbations decreased,
these only represent components of asthma control, and only give us a glimpse of the
potential benefit exercise could have on asthma control.
Other non-intervention studies have evaluated the relationship between components of
asthma control (or asthma control directly) and exercise status. In a longitudinal study by
Garcia-Aymerich et al. (73), a higher level of physical activity was associated to a lower
likelihood of having an asthma exacerbation in older women with asthma. This study
was a prospective study, where women provided medical and personal information
every 2 years starting in 1976. Physical activity assessments were done as of 1998
using a validated 7-day physical activity diary. Type and time spent per week on various
activities was used to calculate metabolic equivalent (MET) hours/week. Information
about symptoms in the last four weeks, number of days kept from work because of
symptoms, and medication in the last 12 months was collected. Asthma exacerbations
were defined as emergency room visits, hospitalisations or urgent medical consultations,
during a period of 12 months in 1999 and 2000. In addition, exacerbations during a 12-
month period (1997-1998), were recorded to determine baseline status. Although this
was not an intervention study, it gives an insight about the potential relationship between
exercise and asthma control.
Westermann et al. (74) evaluated the relationship between level of physical activity and
asthma control in adults. Asthma control was measured using the Asthma Control
Questionnaire (ACQ), designed by Juniper. The Paffenbarger Physical Activity and
Exercise Index were used to assess level of physical activity and exercise. Additional
questions including participation in any sports were asked. Using this information
participants were grouped according to exercise status. Doing any exercise, meeting
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exercise guidelines, moderate- and vigorous-intensity exercise, and exercising 3 or more
days per week were defined as exercise habits. Analyses revealed that people who
exercised were more likely to have better asthma control, however this did not remain
significant in the multivariate analysis making high body mass index the strongest
variable associated with exercise habits. Nevertheless, obesity has been related to
worse asthma (74) as part of a vicious cycle (75): physical inactivity leads to obesity
which leads to worse asthma negatively influence QOL.
2i.2 Asthma Control and Quality of Life
There are a number of studies that have shown a correlation between asthma control
and asthma QOL such that people with poor asthma control have impaired QOL
compared to those with better control (14). Axelsson et al. (14) evaluated if personality
traits in adults were related to health-related QOL and asthma control. The Asthma
Control Test (ACT) was used to assess level of asthma control. The Short-Form-8
Health Survey (SF-8) was used to evaluate health-related QOL. Upon analysis they
found that asthma control and health-related QOL were correlated.
A retrospective study evaluating asthma symptoms and QOL found that adults with no
asthma symptoms reported better asthma QOL (76). Szabó et al. assessed adults over
the age of 30 who had had a diagnosis of asthma during childhood. QOL was assessed
via the AQLQ and asthma symptoms were assessed via a few questions concerning
their current asthma symptoms (76). Adults who had no asthma symptoms scored
higher in the AQLQ than adults who were symptomatic, 6.8 and 5.28 respectively. This
study highlights the impact of symptoms on asthma QOL in adults.
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Also, Erickson et al. (15) found that symptom-derived severity greatly influenced asthma
QOL. Data on asthma QOL and asthma were collected from 603 adults with asthma.
Symptom-derived severity classified symptoms in four categories: mild intermittent, mild
persistent, moderate persistent and severe persistent. These classifications were based
on increasing frequency of symptoms and exacerbations (15). Asthma QOL was
assessed using AQLQ and general QOL was assessed via the SF-36. Both measures of
QOL were significantly related to symptom-derived severity, denoting the link between
asthma symptoms and asthma QOL.
Bloomberg et al. (69) conducted a study to evaluate factors that were related to level of
asthma control in children with asthma. Asthma control was assessed in terms of
frequency of daytime symptoms and albuterol use (a bronchodilator), as well as physical
activity limitations in the past two weeks. Asthma exacerbation history (i.e. oral steroids
and emergency department visits) was also included in the assessment of asthma
control. Asthma QOL was assessed using the PAQLQ. The PAQLQ was significantly
related to asthma control such that children with well-controlled, partially controlled, and
poorly controlled asthma scored 6.5 ± 0.5, 6.2± 0.9, 5.4 ±1.3, respectively.
In summary, aspects of asthma control such as wheeze and symptoms have been
shown to improve following exercise interventions (13, 70-72). In addition, asthma
control and components of it (i.e. daytime symptoms) have been shown to be correlated
with QOL, such that if they improve, so does QOL (14, 69). Unfortunately, no analysis of
overall asthma control has been done following the completion of an exercise
intervention in adults with asthma, leaving us with inconclusive data that exercise can
improve asthma control. Also, as symptoms tend to result in use of bronchodilators, it
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would be interesting to specifically examine how bronchodilator use would be affected
following an exercise intervention.
2j. Bronchodilator Use
As described previously, bronchodilators (i.e., short-acting ß2 agonists) are used at
symptom onset, and relax the smooth muscle surrounding the airway. There is evidence
to suggest that frequent bronchodilator use (i.e. which is a sign of frequent asthma
symptoms) is an important indicator of asthma control and may impact QOL in
individuals with asthma (15).
2j.1 Impact of Exercise on Bronchodilator Use
Improvements in asthma control have been correlated with better QOL in children with
asthma (68, 69). One aspect of asthma control is the frequency of symptoms and
bronchodilator use. Studies done looking at the effects of exercise on asthma medication
use indicate that exercise improves medication use, though the specific details of these
changes in medication use have been ambiguous (72). For example, Neder et al. (77)
assessed the impact of a 2-month indoor aerobic training programme (using a cycle
ergometer) on change in medication score in 26 children with asthma. The training
sessions were 3 times a week, an hour each. The authors assessed medication use
using a medication score. The medication score was calculated on a scale from 0-4,
where a score of O represented someone taking no medication and a score of 4
represented someone taking systemic steroids, high-doses of inhaled steroids and
bronchodilators on demand (78). At the time of the initial evaluation, 22 of the 26
children had medication scores >3 consisting of bronchodilator use, daily ICS use, and
oral corticosteroid use. At the final evaluation, the number of children with a medication
score >3 decreased to 15 (77). Due to the fact that medication score included both ICS
29
and bronchodilator use it is impossible to draw conclusions about the effects of exercise
on bronchodilator use alone. This important distinction needs to be made because
increased ICS use reflects improved adherence (resulting in positive disease outcomes),
whereas increased bronchodilator use reflects poor control.
Basaran et al. (13) measured both ICS and bronchodilator use using the Modified
Asthma Medication Score (MAMS), on a scale from 0 to 7 where 0 = no medication and
7 = oral steroids > 20mg. On the MAMS, lower scores represent only bronchodilator use
and higher scores include bronchodilator and ICS use. Thirty of the 58 children with
mild-moderate asthma were randomized to the exercise intervention group. As stated in
section 2h., the exercise intervention was comprised of basketball sessions 3x/week, an
hour each, for 8 weeks. Within the exercise group, there was a significant change in the
MAMS from 4.93 ± 2.5 to 3.53 ± 2.1 (p<0.001) (13). Due to the fact that this score was
only measuring whether or not a patient was taking medication for their asthma, we
cannot say how bronchodilator use changed. The MAMS more likely assessed asthma
severity. Therefore, this lack of precision regarding bronchodilator use frequency
weakens the suggestive implication of the positive effect of exercise on frequency of
bronchodilator use.
In contrast, some studies did not find improvements in medication use following
exercise. Hallstrand et al.'s (79) intervention consisted of step aerobics 3x/week for 10
weeks. In a sub-analysis of a sample of 10 adult participants (5 participants with and 5
without asthma) who were asked to keep a medication diary before and after an exercise
intervention, Hallstrand et al. (79) found that the participants with asthma did not exhibit
significant changes in bronchodilator use. The type of medication use in the non-asthma
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participants was not reported. Bronchodilator use was a tertiary analysis, thus there was
no detailed information about change in frequency of bronchodilator use.
Robinson et al. (80) evaluated the effects of a circuit training programme in 8 adults with
asthma. The exercise circuit included seven exercises: sit-ups, leg extensions, dumbbell
punch and lateral dumbbell raise, cross country ski machine, cycling and treadmill
running. Each exercise was done for 50 seconds with a minimum rest period of 30
seconds in between each exercise. Participants completed the circuit 1-4 times per
session, for 12 weeks and were instructed to aim for 3x /week. Included among the
many outcome measures was a diary of bronchodilator use for the duration of the
training intervention. Authors found no change in bronchodilator use over the time of the
training program (80). Due to the fact that bronchodilator use was not the main outcome
measure, no detailed information on bronchodilator use was given.
In summary, there is evidence that supports the notion that exercise can improve
medication use in individuals with asthma, such that there can be changes in ICS and/or
bronchodilator use and symptom frequency post-intervention. Two studies found
decreased medication scores (13, 77), however, bronchodilator use was not properly
defined nor treated separately from ICS use, thus limiting the interpretability of these
results. Additionally, these studies included patients who were not sedentary prior to
beginning the exercise intervention, (77) rendering it impossible to ascertain that any
medication improvements were solely due to beginning an exercise programme.
Inconsistencies remain regarding the impact of exercise on medication use, specifically
bronchodilator use, with studies reporting no change in bronchodilator use following an
exercise (79, 80). Thus, the impact of an exercise intervention on bronchodilator use
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needs to be explored further, especially since we know that bronchodilator use (a result
of symptoms) can affect QOL (68, 69, 76).
2k. Impact of Exercise on Lung Function
A systematic review of all RCT studies that conducted aerobic exercise interventions
with individuals with asthma eight years of age and older found no impact of exercise on
lung function (16). In short, 13 studies were included in this review; all studies had
aerobic exercise intervention lasting a minimum of 4 weeks, 20-30 minutes per session,
2-3x/ week. Nine studies evaluated FEV1 and FVC and found no significant changes in
either measure of lung function following the exercise interventions. Although the
majority of the research suggests that exercise interventions in people with asthma do
not improve lung function, there are a few studies that did find otherwise. One can
speculate that the type of exercise, intensity, duration and programme may be a reason
why there are inconsistencies in the literature. One study suggested that improvement in
lung function may have been due to optimization of medical treatment (66).
2I. Summary
There have been a number of studies evaluating the effects of exercise on children with
asthma. These studies have used a variety of outcome measures, including lung
function, symptom frequency, cardiovascular benefits, as well as QOL. Notwithstanding,
very few studies have been conducted evaluating the effects of exercise, and specifically
aerobic exercise, on QOL in an adult population of asthmatics. As detailed above, of the
studies that have been conducted assessing the impact of exercise on QOL, they have
all suffered from various limitations. For example, including participants who were
physically active prior to being included in the study (81), giving educational sessions as
part of the intervention (8, 66), and using a variety of questionnaires to assess QOL,
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none of which were asthma specific ((63); see Table 1). These limitations are important
because they do not allow us to evaluate patients who are likely to benefit the most from
an exercise intervention (i.e., sedentary patients); the specific or unique effects of
exercise on asthma; or assess domains of QOL that are specific to people with asthma.
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Chapter 3: Rationale
Although effective treatments for asthma are widely available, many patients with
asthma remain poorly controlled and, as a result, have a poor QOL. Exercise training
has been shown to have a therapeutic effect in other medical conditions such as heart
disease (59) and breast cancer (60). Among the studies that have evaluated the effects
of exercise on asthma, most have focused on outcome measures such as lung function
and exercise capacity. However, very few have assessed the impact of aerobic exercise
on asthma QOL, and none have assessed asthma QOL in adults, which is a clinically
significant measure that is often of great importance to the patient. This pilot study was
necessary to increase researchers understanding of the potential benefit that an aerobic
training programme may have on QOL in adult patients with asthma. In addition, few
studies have looked specifically at asthma control and bronchodilator use which have
been correlated with QOL. This pilot study will also provide clinicians more evidence of
the effects of aerobic exercise on their patients' QOL and may potentially aid in the
promotion of more exercise protocols as an adjunct treatment. The results of this pilot
study could also be the catalyst for future projects, e.g., a full-scale trial or the evaluation
of various modes of exercise (for example resistance training).
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Chapter 4: Objectives and Hypotheses
This pilot study aimed to assess the effects of a 12-week aerobic exercise programme
on asthma QOL, asthma control and bronchodilator use in adults with asthma. This pilot
study also served to provide data for power calculations for the design of a future full-
scale randomised controlled trial.
4a. Primary Objective
1) To evaluate changes in asthma quality of life in sedentary adults diagnosed
with asthma following a 12-week aerobic exercise intervention.
Hypothesis
It was hypothesized that after completing a 12-week aerobic exercise intervention,
previously sedentary participants with asthma would report statistically and clinically
significant improvements in quality of life according to scores on the Asthma Quality
of Life Questionnaire, reflecting a reduction in the limitations caused by their asthma.
4b. Secondary Objective
1) To assess the effects of a 12-week aerobic exercise intervention on asthma
control in a sample of sedentary adult asthmatics
Hypothesis
Following the 12-week aerobic exercise intervention, participants would demonstrate
a significant improvement in asthma control as measured by the Asthma Control
Test and the Asthma Control Questionnaire, two questionnaires that have been
validated to assess asthma control. This improvement would also be strongly
correlated with improvements in asthma quality of life.
35
2) To assess the effects of a 12-week aerobic exercise intervention on the
frequency of bronchodilator use in a sample of sedentary adult asthmatics
Hypothesis
Following a 12-week aerobic exercise intervention, participants would exhibit a
significant decrease in the frequency of bronchodilator use in the week following the
end of the intervention relative to the week prior to study entry as assessed by a one-
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Quality of life in chronic disease populations is becoming increasingly important. There is
a paucity of studies evaluating the impact of aerobic exercise on quality of life in adults
with asthma. This pilot study examined the efficacy of a 1 2-week aerobic exercise
intervention on quality of life in sedentary adults with asthma. Four adults with asthma
were recruited for the pilot project and completed the Asthma Quality of Life
Questionnaire (AQLQ) prior to and after completing the exercise intervention. Following
the intervention, participants demonstrated a clinically significant improvement in total
asthma quality of life, which was not statistically significant (?1.22 ±1.13 F = 4.63, ? =
.12). However, participants demonstrated statistically significant improvements in the
symptoms domain of the AQLQ (3.75 ± 0.59 to 5.31 ± 1 .09; F= 10.96, p=.045).
Participants also demonstrated statistically significant improvements in asthma control,
as assessed by the Asthma Control Questionnaire (ACQ) (2.54 ± 0.74 to 0.82 ± 0.52; F=
36.03, p=.009) and the Asthma Control Test (ACT) (13.25 ± 3.30 to 21 ± 1.83; F= 23.44,
p= .017). No significant changes were found for bronchodilator use, FEV1, or FEV1ZFVC,
V02max. Consistent with the results obtained in other clinical populations, results of this
pilot study suggest that aerobic exercise in adults with asthma may improve quality of life
and clinically important aspects of asthma such as asthma control.
Shortened Title: Exercise and Asthma Quality of Life
Keywords: asthma, quality of life, adults, aerobic exercise, asthma control
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5b. Introduction
Quality of life (QOL) is an important concern among clinical populations. Generally
defined as one's ability to function optimally and enjoy life, QOL can be affected by
financial status, occupational environment, and health (52). In terms of health, disease-
specific QOL measures the impact of a disease on one's ability to function in daily life
(53, 54). In 2005, 8% of the Canadian population over the age of 12 (-2.2 million people)
were diagnosed with asthma (6). Asthma has been directly related to increased work
and school absences, an inability to perform household chores, a restriction of social
activities (20), and a general decrease in QOL (21-23), making it a major health and
societal concern in Canada. However, in addition to its prevalence, the control of asthma
in Canadians is generally poor with more than 50% of Canadians having poor control of
their asthma (25). Defined as one's ability to control or manage manifestations of the
disease, asthma control can negatively affect the QOL of patients suffering from this
chronic inflammatory disease.
Exercise has been shown to be beneficial to overall health and more specifically, has
been shown to reduce morbidity associated with obesity, type Il diabetes, and
hypertension (9). Exercise has numerous benefits in healthy populations, including
improved cardiovascular and cardiorespiratory capacity, as well as improved QOL (82,
83). In respiratory diseases such as chronic obstructive pulmonary disease (COPD),
exercise has been shown to improve outcome measures such as exercise tolerance and
QOL (11). Studies conducted in other clinical populations, such as coronary artery
disease, have also found improvements in QOL after participating in exercise
programmes. (10).
39
Previous studies have evaluated how exercise improves QOL in patients with asthma.
However, most of these studies were conducted in paediatric populations. Among these
are studies by Basaran et al. (13) and Fanelli et al. (12) which found that children with
asthma who completed an exercise programme demonstrated improvements in asthma
QOL compared to baseline, as measured by the Paediatric Asthma Quality of Life
Questionnaire (PAQLQ) (12, 13). In addition, Cambach et al. (63) found improvements in
post-exercise intervention measures of health-related QOL in adults with asthma.
However, this study did not use an asthma-specific measurement tool to assess QOL.
To our knowledge, no exercise intervention studies have evaluated disease-specific
QOL changes in adults with asthma. Thus, the primary objective of this pilot study was to
determine whether 12 weeks of aerobic exercise could improve asthma QOL in
sedentary adults with asthma. We hypothesized observing a statistically and clinically
significant improvement in asthma QOL following the completion of the exercise
intervention.
5c. Methods
5c.1 Participant recruitment and screening
Participants were recruited from the asthma tertiary care clinic at l'Hôpital du Sacré-
Coeur de Montréal (HSCM) between January 2008 and June 2009. All participants
provided signed informed consent prior to data collection. Participants were included if
they were 18 years and older, sedentary (i.e., engaged in less than 60 minutes of
planned physical activity per week), had physician-diagnosed asthma (i.e. airway
reversibility/metacholine PC20 < 16mg/ml) for which they were prescribed a minimum
dose of inhaled corticosteroids (ICS) of 250mg per day, and had mild to moderate
asthma symptoms. Mild to moderate symptoms were defined as using bronchodilator
medication 2-4 times per week and/or having night awakenings 1-2 times per week.
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Participants who were unable to communicate in English or French, had a co-morbid
disease that was more serious than asthma (e.g., COPD), or a co-morbid disease for
which they had previously established exercise guidelines (e.g., cardiac rehabilitation
programme) were excluded from the study. The study was approved by the research
ethic boards of both HSCM and Concordia University and all participants provided
written informed consent.
5c.2 Screening Procedure
Patients who were referred by a physician were contacted by telephone by a research
assistant and were given a brief overview of the study and eligibility criteria were verified.
The research assistant briefly explained the project and asked questions including: "do
you exercise regularly" and "how many times have you used your bronchodilator
medication in the past week", etc. If patients were sedentary, had been using their
bronchodilator medication regularly, and were interested in participating in the project,
they were invited to participate in an in-person screening interview. Patients who were
seen at the clinic and were interested in participating in the study either had their
screening interview during the clinic visit or were scheduled for an interview
approximately one week later. During the screening interview, the Asthma Control
Questionnaire (ACQ) was used to screen participants for eligibility. Participants with a
mean score less than 1.5 were considered to be well controlled and were excluded.
Next, participants completed a medical history and socio-demographic questionnaire.
This questionnaire contained self-report information about weight and height, current
asthma medication, health behaviours such as current levels of physical activity,
smoking status and medication adherence. It also included a brief medical history of
conditions other than asthma and information about their family's medical history. For
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additional screening purposes, participants were given a one-week diary where they
indicated the frequency of bronchodilator medication use, the activity triggering the use
of their bronchodilator medication, the symptom severity, and whether or not they had
any nocturnal waking asthma symptoms the night before. Baseline assessments were
conducted on those patients that met all eligibility criteria.
5c.3 Baseline and Post-intervention Measures
Measures included administration of the ACQ, Asthma Control Test (ACT) and Asthma
Quality of Life Questionnaire (AQLQ). Objective testing included standard lung function
testing by full body plethysmography and graded-exercise test on a cycle ergometer.
These assessments were also repeated following the completion of the exercise
programme.
5C.3.1 Quality of Life Assessment
Assessment of QOL was done using the disease-specific AQLQ developed by Juniper
(84). This questionnaire assesses the extent to which asthma limits an asthmatic's life or
interferes with his or her ability to do and/or enjoy daily activities. This questionnaire
includes 32 items, rated on a 7-point scale (i.e., 1= a great deal of limitations to 7= no
limitations at all) and has a two-week recall. The AQLQ is scored using the mean score
of the questionnaire, with a higher score indicating better QOL. The AQLQ is divided into
subscales that measure four aspects of life typically affected by asthma: activity
limitations (how asthma limits the ability to carry out daily activities), symptoms (nature
and frequency of symptoms), environment (level of difficulty for patients to manage or
avoid environmental asthma triggers), and emotional distress (the degree of emotional
stress caused by the disease). The AQLQ has high intra-class correlation coefficients
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(0.95) and good construct, cross-sectional, and longitudinal validity (85-87). A change or
difference of > 0.5 in the AQLQ has been shown to be clinically significant (88).
5C.3.2 Asthma Control Assessments
Asthma control was assessed using the ACQ also developed by Juniper (89). It is a self-
report instrument consisting of 7 questions relating to the level of asthma control in the
past week. This questionnaire asks patients to recall the frequency and intensity of their
asthma symptoms and bronchodilator use over the last week. The seventh additional
question is concerning objective lung function values and may also be included in the
score, and is completed by the respiratory technician who conducted lung function tests
(90). Scores range from 0 (complete asthma control) to 6 (poor asthma control) (90),
with a lower score indicating good control. The level of control is calculated by taking the
mean score of the questionnaire. The ACQ has an intra-class correlation coefficient
0.90, good construct, cross-sectional and longitudinal validity (89, 90). A change of > 0.5
in the ACQ has been shown to be clinically significant (54).
The ACT is another questionnaire that evaluates level of asthma control. The ACT,
designed by Nathan, consists of 5 items rated on a 5-point scale (91). This questionnaire
has a four week recall and requires participants to recall symptom frequency,
bronchodilator use, etc. (similar to the ACQ), however does not include objective lung
function. Scoring ranges from 5 (poor asthma control) to 25 (completely controlled). The
questionnaire score is based on the sum total score; with a sum score >20 indicating
good control. The ACT has good internal consistency reliability (0.84) and a test-retest
reliability of 0.77 (91, 92). It has also been shown to be responsive to change in asthma
control over time. Although the ACT was more recently developed, it has also been
widely used, though there is less validation data available than the ACQ (93). The
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exclusion of the objective measure of lung function makes this questionnaire easy to use
and practical for clinical use. Even without the lung function measure the ACT remains
highly correlated with changes in ACQ (/=-0.81, p<.001) (92).
5C.3.3 Lung Function
As per standard protocols for lung function testing, bronchodilator medication was
withheld for at least 4 hours prior to the assessment. The tests consisted of diffusion
capacities, lung volumes and spirometry using the Vmax encore Plethysmograph
(Sensormedics, Yorba Linda, CA). Spirometry included forced vital capacity (FVC) and
forced expiratory volume in one second (FEV1). Patients were assessed before and 15
minutes after the administration of 200 pg of salbutamol using a metered-dose inhaler or
500 pg terbutaline using a Turbuhaler®. All results were compared to standard normal
values (94-98).
5C.3.4 Exercise Capacity
Participants were required to undergo a standard fitness evaluation as recommended by
the American Thoracic Society (99). This was done using an electrically braked cycle
ergometer (Ergometrics 800, Sensormedics, Yorba Linda, CA), applying the Jones stage
1 exercise protocol. The Jones stage 1 protocol required participants topedal on the
cycle ergometer at 60 revolutions per minute with no resistance or with mild resistance
(20 Watts) if the participant was in moderate physical condition. The resistance was
increased every minute by 15 Watts and the participants were instructed to exercise to
exhaustion (until leg fatigue, shortness of breath). Heart rate, blood pressure, minute
ventilation, carbon dioxide (CO2) excretion and oxygen (O2) uptake were recorded during
the test and active recovery. As per standard practice, (100, 101) minute ventilation
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(VE), oxygen uptake (VO2) and CO2 excretion (VCO2) was analyzed on a breath-by-
breath basis.
5c.4 Exercise Intervention
The intervention was comprised of 36 sessions at a frequency of 3 sessions per week on
non-consecutive days for 12 weeks. Each session consisted of a 10-min warm-up, 40-
min aerobic exercise using the participants' choice of equipment (elliptical trainer,
treadmill, or stationary bicycle), followed by a 10-min cool-down. Participants were not
obliged to continue for 40 minutes on one piece of equipment; rather they had the option
to do 3 blocks of exercise for a total of 40 minutes. For the first 4 weeks, participants
were required to work at 50-75% of their heart rate reserve (defined from the initial
maximal exercise test). During the remaining 8-weeks, the intensity increased to 70-85%
of their heart rate reserve. Their exercise intensity was calculated using the Karvonen
method (102). Heart rate was verified at random times during each session, using a
heart rate monitor, to assure that participants were exercising at the appropriate intensity
level. To reduce the risk of having an exercise-induced bronchospasm all participants
were obligated to pre-medicate with their bronchodilator prior to each session, which has
been shown to be an effective preventative measure (103-106).
5c.5 Statistical Analysis
Data analysis was done using SAS version 9.1 (SAS, Durham, NC). A series of repeated
measures general linear models were conducted to compare the pre and post- values of
the AQLQ (total and subscale scores), ACQ, and ACT and bronchodilator use. In
addition, analyses were conducted to compare pre- and post- values of FEV1 and
V02max. All analyses were two-sided. One participant did not complete their post-
intervention spirometry assessments. To compensate for the lost data, and in line with
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intention-to-treat principles, we used a last value brought forward procedure to replace
the missing values (107). To identify potential mechanisms of any effect, a series of
Pearson correlation analyses were used to assess the relationships between AQLQ
scores (total and each subscale) and the following variables: ACQ change, AGT change,
bronchodilator change, FEV1 change, FEV1ZFVC change, and V02max change.
Significance (alpha) was set at .05 for all analyses. Due to the small sample size and




A total of 4 adults with asthma participated in the study. Figure 6 depicts the recruitment
flowchart for patients who presented to the HSCM clinic. A total 1084 participants
presented to the HSCM clinic between January 2008 and June 2009. A total of 851
patients, including 356 who were approached, were excluded; 23 patients' had
undetermined eligibility; 172 were not approached. Of the 38 patients who were eligible,
4 were recruited. Participant demographics can be found in Table 2.
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n=18 did not want to hear about
research























n=4 lived too far
n=9 refused
n=4 unable to contact





Patients at clinic represent the total number of patients who presented to the external asthma clinic at
HSCM.
47
Table 2 Participant demographic
N/ Mean ± standard deviation Range
N 4
Sex (# of females) 3
Age (years) 41.6 ±16.5 27.1-61.5
Years with asthma 17.3 ±6.8 12.0-25.0
ICS dose (mg) (including 875.0 ± 478.7 500.0-1500.0
combined beta 2)
# of times bronchodilator 6.3 ±1.5 5.0-8.0
(in past week)








All participants attended more than 75% of the exercise classes with an average
attendance of 82% of the classes. Participants missed sessions due to illness,
work/school conflict, etc. During the Christmas holiday season, training was suspended
for one week, but all participants completed 12 weeks of exercise.
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5d.3 Asthma Quality of Life
As seen in Figure 7, after completing the exercise intervention, participants
demonstrated clinically significant improvements in the mean total AQLQ, with an
increase of 1.22 ± 1.13, which was surprisingly not statistically significant. This
represented a 29% improvement in AQLQ. The mean change of each subscale was:
1.56 + 0.94 (symptoms); 0.95 ± 1.26 (emotions); 0.63 ±2.11 (environment) and 1.19 ±
1.19 (activity limitations). Table 3 depicts the group mean of each subscale of the AQLQ
and other outcome measures pre- and post-intervention.
5d.4 Asthma Control
Participants demonstrated both statistically and clinically significant improvements in
asthma control measured by both the ACQ and the ACT following the intervention, with
a mean -1 .67 ± 0.56 changes in ACQ (Figure 8) and the mean 7.75 ± 3.20 changes in
ACT of (Figure 9). As represented by both measures, our group started out poorly
controlled (ACQ > 1 .5 and ACT < 20). However, most participants went from
uncontrolled to controlled following the exercise intervention, with the exception of one
participant who was borderline (ACT score=19). Changes of 0.5 represent clinically
significant changes in asthma control measured by the ACQ (54), and our participants
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Although participants did demonstrate important improvements (reductions) in
bronchodilator use (Table 3) following the intervention, this change was not statistically
significant.
5d.6 Lung Function and Exercise Capacity
Participants did not demonstrate any significant changes in FEV1 (F=6.04, p=.09),
FEWFVC (F=6.52, p=.08), or absolute V02max (F=0.01, p=.94) (Table 3) following the
intervention.
5d.7 Correlation Analyses
As seen in Table 4, correlation analyses revealed that changes in asthma control (both
ACQ and ACT) predicted changes in total AQLQ. In addition, changes in asthma control
correlated with changes in all 4 of the AQLQ subscales; however this was only
statistically significant between the ACT and the emotions subscale (Table 5). Change in
bronchodilator use was significantly related to change in the emotions subscale for the
AQLQ. Changes in FEV1, FEV1ZFVC, and V02max did not predict changes in total AQLQ


























































































































































































































































































































































































Table 4 Correlation between change in total AQLQ and change in asthma control








Weekly bronchodilator use 0.92 .084



















































































































































































































































































The current study found that a 12-week aerobic exercise intervention in adults with
asthma produced a clinically important improvement in the total AQLQ score, which did
not reach statistical significance. Assessment of each AQLQ subscale showed a
statistically important improvement only in the symptoms subscale. Asthma control,
measured by the ACQ and ACT, demonstrated both clinical and statistical improvements
following the exercise programme. In addition, we found significant correlations between
both measures of asthma control and total AQLQ and found a significant correlation
between the ACT and emotions subscale. We also observed that on average, there was
more than a 50% decrease in bronchodilator use in the week following the exercise
programme compared to the week prior to starting. However, this improvement did not
reach statistical significance. Change in bronchodilator use was also significantly related
to changes in the emotions subscale of the AQLQ.
5e.1 Asthma Quality of Life
Some of our results are consistent with studies that have assessed asthma-specific QOL
following an exercise intervention. For example, Fanelli et al. (12) found that children
with asthma had significant improvements in QOL following a 16-week exercise
programme and Basaran et al (13) also found improvements in QOL of children with
asthma after an 8-week exercise programme. While Basaran reported a 24%
improvement in total PAQLQ scores, similar to our findings, Fanelli reported a 75%
improvement in total PAQLQ scores, which is almost three times the magnitude of
change we observed. However, this could be in part explained by the extremely low
baseline PAQLQ scores and the inclusion of education classes for children prior to
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starting the exercise intervention. Similar to our study, both Basaran and Fanelli also
found improvements on all subscales of the PAQLQ. These studies also found no
correlation between QOL and exercise capacity and lung function (12, 13), which is
consistent with our findings that suggest that the improvements in AQLQ appeared to be
independent of changes in FEV1, FEV1ZFVC and V02max. In addition, our results are
also consistent with two exercise interventions conducted in adults. Cambach (63) found
that after 3-months of exercise, adults with asthma showed significant improvements in
QOL measured by the Chronic Respiratory Disease Questionnaire (CRDQ). The two
groups, RC (exercise condition then control) and CR (control condition then exercise)
demonstrated a 68% and 80% improvement in QOL, a magnitude that was more than
two times greater than what was observed in the present study. Cambach also, found no
significant correlation between changes in exercise tolerance (endurance time,
submaximal exercise and walking distance) and QOL (63). Emtner (8) also found 3 out
of 5 Visual Analog Scale (VAS) items improved significantly following the 10-week
exercise intervention in adults. Although the VAS was not specifically designed to
assess QOL, the items included aspects that are related QOL (e.g., I am afraid of
experiencing breathlessness when I exercise) (8).
5e.2 Asthma Control
To our knowledge, there have not been any interventional studies that specifically
evaluated the impact of an exercise intervention on asthma control (i.e., using the ACQ)
among adult asthmatics. However, some intervention studies examined components of
asthma control and their outcomes following an exercise programme. One study found
that following a swimming programme, children with asthma reported less wheeze days
when compared to baseline (71). Other observational studies have looked at
components of asthma control such as the frequency of asthma exacerbations, and its
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relationship to physical activity. A prospective longitudinal study of physical activity and
rates of asthma exacerbations found that women who were regularly physically active
had a lower risk of having an asthma exacerbation than those who were less physically
active (73). Also, a study done in children related more TV-time (more sedentary
behaviour) with an increased risk of asthma symptoms (108). Taken together, these
studies suggest that a more physically active lifestyle can lead to better asthma control
which is in line with the present findings. Another study found that people who had well-
controlled asthma were more likely to participate in vigorous-intensity exercise (74).
Although the latter study used the ACQ to measure asthma control, due to its cröss-
sectional nature, we cannot interpret whether the reverse is true, i.e. do patients have
good control because they exercise? Nevertheless, it is difficult to compare our study to
these studies, due to the fact that they employed different designs (i.e., cohort studies
versus an intervention).
5e.3 Bronchodilator Use
Our findings in regards to bronchodilator use is consistent with those of Hallstrand's (79)
who did not observe any change in bronchodilator use frequency following a 10-week
step aerobic exercise intervention. In contrast to our study other studies have found
changes in asthma medication use following an exercise intervention, demonstrating that
exercise may influence medication use (13, 77); however type of medication was not
specified nor treated independently. Basaran (13) and Neder (77) both reported reduced
medication scores following exercise interventions in children with asthma. However,
these medication scores assessed not only bronchodilator use but ICS use, which does




There may be a few potential mechanisms to explain the clinical improvements seen in
QOL in our study. Previous studies have shown that there is a relationship between
asthma control and asthma QOL (14) such that poor control tends to impair QOL.
Assessment of asthma control (ACQ and ACT) focuses on bronchodilator use, symptom
frequency and severity. The AQLQ involves questions that assess how symptoms affect
QOL. Therefore, with such a significant improvement in asthma control, we would expect
there to be similar improvements in the total AQLQ score, and, unsurprisingly, in the
symptoms subscale, given that it assesses the impact of asthma symptoms (i.e., asthma
control) on quality of life. Subsequently changes in asthma control could be a result of
change in inflammatory profile. A study conducted in mice found that 4 weeks of
treadmill exercise resulted in a decrease in airway inflammation (109). Due to the fact
that airway inflammation is the cornerstone of asthma, this may likely influence asthma
control and consequently QOL.
Studies have shown that exercise can positively impact psychological health (e.g. mood,
anxiety, and stress) (110, 111). For example, a review of studies looking at the effects of
exercise on depression, anxiety, and other mood states found that exercise, which was
predominantly aerobic exercise, positively impacted these psychological states (111). In
addition, it has been shown that psychological health may be correlated with asthma
QOL, such that patients with asthma with psychiatric disorders have decreased QOL
(112). It is possible that the exercise intervention in our study led to an improvement in
psychological status, which in turn led to increased QOL. However we did not find any
change in the emotions subscale of the AQLQ, suggesting that our intervention may not
have had any impact on psychological health.
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Finally, exercise has been shown to improve functional capacity (13). This was
demonstrated in a study done in children after completing a basketball program and also
in adults with asthma and COPD following an aerobic exercise intervention (13, 63).
Although functional capacity may be a mechanism for improvement in QOL we did not
observe any changes in the activity limitation subscale of the AQLQ. This could suggest
that our intervention was not effective in decreasing the impact that asthma had on our
participants' activities of daily living (i.e. their ability to function).
5e.5 Manipulation Tests
5e.5.1 Lung Function
In contrast to a few studies (8, 66) where improvements in FEV1 and FEV10Zo post-
exercise intervention were found, we found no such changes in any measure of lung
function (i.e. FEV1, FEV1ZFVC) following exercise, which is consistent with numerous
studies in asthma populations (16, 113). A systematic review of exercise and asthma
revealed that 9 of 1 3 studies that assessed lung function (FEV1 and FVC) found no
changes following the interventions (16). All studies included in the review had to have
interventions that were at least 4 weeks long, 20-30 sessions done 2-3 times per week,
thus covering a wide range of exercise interventions.
5e.5.2 V02max
None of our participants demonstrated changes in absolute V02max, which is
inconsistent with previous literature in adults. In the same review of exercise and
asthma, 7 of the 13 studies that evaluated V02max found improvements (A5.4ml/kg/min
95% Cl= 4.24 to 6.61). The negative findings observed in the present study may be due
to the different equipment used for the V02 assessment and during training. Our
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participants had the option of using a variety of equipment during the exercise phase;
most participants preferred the elliptical trainer and treadmill, and reported less interest
in using the bicycle (i.e. finding it 'too tiresome on the legs'). We used a cycle ergometer
to do both the baseline and post-intervention testing because this is standard practice in
a pulmonary clinic setting (as it is reported to be safer and requires less leg muscle
training than treadmill use (114)). Research has shown that specificity is important when
assessing V02max, such that to maximise improvements in fitness, individuals should be
using the same mode of exercise for training and testing (115). Thus the inconsistent
modalities between testing and training could have diluted any improvements in fitness.
5e.6 Limitations
The small sample size was the major limiting factor of this pilot study. Many people were
excluded due to disease comorbidity, having occupational asthma, or having an
unconfirmed case of asthma, leaving us with a small pool of eligible candidates for the
study. This factor combined with our self-selection bias, limits our generalizability to
patients with asthma. Despite this, a secondary purpose of the current study was to
provide pilot data for power calculations for a larger full scale randomised controlled trial,
which was achieved. Of note, we performed a post-hoc power analysis on the data
which revealed a power of 0.96 with an effect size of 1 .7, suggesting that our exercise
intervention had no effect on QOL. We also did not have a control group, thus not
allowing us to determine whether improvements were due to our intervention or due to
participating in a research project (i.e. being followed up more frequently). However the
objective of this study was to first determine efficacy of the exercise intervention. Also,
we depended on self-reported data for our questionnaires which may have introduced
some reporting bias. However they have been validated in this manner (89, 91, 116).
Finally, the inconsistent training modality between exercise training and testing
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potentially diluted any fitness improvements. This contradicts the specificity principle
showing that one should employ the same mode of exercise for both testing and training
to maximise fitness improvements (115). To avoid this hindrance in future studies, the
exercise intervention should be designed to adhere to the specificity principle (1 14). A
limitation of not only ours, but all exercise interventions in asthma, is the lack of
consistency in the exercise modality, frequency, and duration used. For example, some
studies incorporated resistance training and some included group sports, whilst others
used recreational activities. This lack of consistency limits the ability to compare across
the studies. In addition, some studies that assessed QOL did not limit themselves to just
an exercise intervention but included education classes or breathing and relaxation
components (12, 13, 63). The inclusion of these additional components may have
addressed other the other aspect of asthma QOL that our programme did not, however
this makes our programme unique in that we can evaluate the effect of only exercise on
asthma QOL.
5f. Conclusion
In conclusion, our study found that 12-weeks of aerobic exercise in adults with asthma
resulted in clinically significant improvements in asthma QOL. The results of this
preliminary pilot study suggest that the integration of exercise intervention programmes
in the treatment of asthma may be a good adjunct to traditional therapies. Due to the
nature of our study, we could not evaluate other potential mechanisms for our findings
such as psychological health or attention affects associated with being in a study. Thus,
future large-scale randomized control trials are necessary to evaluate other factors that
may impact and mediate the relationship between exercise and asthma QOL.
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